OnKure Therapeutics OKUR
NASDAQ OKUR
$2.58 +0.28 (+12.17%)
At close: Oct 22, 2026 · 4:00 PM EDT

OnKure Therapeutics (OKUR) Depreciation & Amortization (CF) (2020 - 2026)

Updated

OnKure Therapeutics (OKUR) posted Depreciation & Amortization (CF) of $87,000 for Q2 2026, down 25.6% from $117,000 a year earlier and down 16.3% from the prior quarter.

Analysis

OnKure Therapeutics (OKUR) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at OnKure Therapeutics was $403,000, down 13.3% year-over-year; for FY2025, it came in at $447,000, down 2.6% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 64.6% (FY2020 to FY2025).
  • In prior years, OnKure Therapeutics' Depreciation & Amortization (CF) was $459,000 in FY2024 (+10.1%), $417,000 in FY2023 (+373.9%), $88,000 in FY2022 (+76.0%) and $50,000 in FY2021 (+35.1%).
  • The Q2 2026 figure stands as the lowest quarterly Depreciation & Amortization (CF) since Q3 2023.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last four quarters, with growth averaging 7.1% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q1 2024, with growth of 178.0%; the weakest was Q4 2024, with a decline of 60.1%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $104,000 (Q1 2026), $104,000 (Q4 2025) and $108,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 2.12 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 194.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 1.93 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 98.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 1.62 Bn
10 OnKure Therapeutics 104.48 Mn -393.44 Mn - 87,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 87,000.00
Mar 31, 2026 104,000.00
Dec 31, 2025 104,000.00
Sep 30, 2025 108,000.00
Jun 30, 2025 117,000.00
Mar 31, 2025 118,000.00
Dec 31, 2024 116,000.00
Sep 30, 2024 114,000.00
Jun 30, 2024 115,000.00
Mar 31, 2024 114,000.00
Dec 31, 2023 291,000.00
Sep 30, 2023 43,000.00
Jun 30, 2023 42,000.00
Mar 31, 2023 41,000.00
Dec 31, 2022 25,000.00
Sep 30, 2022 22,000.00
Jun 30, 2022 22,000.00
Mar 31, 2022 19,000.00
Dec 31, 2021 17,000.00
Sep 30, 2021 13,000.00
API Access

OnKure Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=OKUR&period=max&api_key=YOUR_API_KEY